Charing Ching-Ning Chong
Overview
Explore the profile of Charing Ching-Ning Chong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
378
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Chong C, Pittayanon R, Pausawasdi N, Bhatia V, Okuno N, Tang R, et al.
Dig Endosc
. 2024 Mar;
36(8):871-883.
PMID: 38433315
Objectives: This consensus was developed by the Asian EUS Group (AEG), who aimed to formulate a set of practice guidelines addressing various aspects of endoscopic ultrasound-guided tissue acquisition (EUS-TA). Methods:...
3.
Siu-Ting Lau R, Ip P, Wong G, Wong V, Jun-Yee Lo E, Kam-Cheung Wong K, et al.
Surgeon
. 2021 Feb;
20(2):78-84.
PMID: 33640283
Background And Aim: Hepatocellular carcinoma is one of the commonest cancer in the world. Despite curative resection, recurrence remains the largest challenge. Many risk factors were identified for predicting recurrence,...
4.
Tang P, Zhang Y, Xiao J, Chiu-Tsun Tang P, Chung J, Li J, et al.
Proc Natl Acad Sci U S A
. 2020 Aug;
117(34):20741-20752.
PMID: 32788346
Unresolved inflammation can lead to tissue fibrosis and impaired organ function. Macrophage-myofibroblast transition (MMT) is one newly identified mechanism by which ongoing chronic inflammation causes progressive fibrosis in different forms...
5.
Koh C, Lakhtakia S, Kida M, Lesmana C, Ang T, Vu C, et al.
Endoscopy
. 2020 Jul;
53(6):595-602.
PMID: 32650341
Background: Although endoscopic ultrasound (EUS) features and criteria have been described in chronic pancreatitis, challenges remain with interoperator variability and ease of adoption. The aim of this study was to...
6.
Chan S, Wong L, Chan K, Chow C, Tong J, Yip T, et al.
Liver Cancer
. 2020 May;
9(2):167-181.
PMID: 32399431
Background: The aim of current study was to (1) construct and validate a novel hepatocellular carcinoma (HCC)-specific inflammatory index; (2) compare the performances of the Integrated Liver Inflammatory Score (ILIS)...
7.
Chan T, Chan W, Wong G, Chan A, Mustapha N, Chan S, et al.
Am J Gastroenterol
. 2020 Mar;
115(6):867-875.
PMID: 32149781
Objectives: Previous exposure to hepatitis B virus (HBV) may increase the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis C. We aim to study the impact of previous...
8.
Liu R, Wakabayashi G, Palanivelu C, Tsung A, Yang K, Goh B, et al.
Hepatobiliary Surg Nutr
. 2019 Sep;
8(4):345-360.
PMID: 31489304
The robotic surgical system has been applied to various types of pancreatic surgery. However, controversies exist regarding a variety of factors including the safety, feasibility, efficacy, and cost-effectiveness of robotic...
9.
A comparability study of immunohistochemical assays for PD-L1 expression in hepatocellular carcinoma
Shi L, Zhang S, Chen J, Lu S, Fan X, Tong J, et al.
Mod Pathol
. 2019 Jun;
32(11):1646-1656.
PMID: 31231126
Programmed death ligand 1 (PD-L1) protein expression by immunohistochemistry is a promising biomarker for PD-1/PD-L1 blockade in hepatocellular carcinoma. There are a number of commercially available PD-L1 assays. Our study...
10.
Fung S, Cheung P, Yip C, Ng L, Cheung T, Chong C, et al.
Cancer Lett
. 2019 May;
457:98-109.
PMID: 31100412
ATP-binding cassette (ABC) transporters mediate multidrug resistance and cancer stem cell properties in various model systems. Yet, their biological significance in cancers, especially in hepatocellular carcinoma (HCC), remains unclear. In...